Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by ggh2257on Nov 25, 2016 3:09pm
409 Views
Post# 25515103

Can't beat the house...

Can't beat the house...Obiously we are not following the same rules; bought an extra 5800 shares at $2.40 with Desjardins at 12:26 today and it went to 4 transactions of 2900+2700+100+100. Before and after me I could see multiples 100 shares going from Morgan Stanley to Merryl Lynch... Within secs they dropped it again to $2.39. They are definitely not paying $9.95 per transactions... Anyway I would prefer the SP to stay up and place extra money elsewhere... I'm fed up buying PLI on the way down. I'm not worry about PL and management, I am more worried about the BioPharm landscape and consolidation coming strongly, there is many big players around with lots of liquidity! GLTA!
Bullboard Posts